Alle Storys
Folgen
Keine Story von Wacker Chemie AG mehr verpassen.

Wacker Chemie AG

2007 Annual Shareholder Meeting: WACKER confirms positive Outlook for current Fiscal Year

Munich (euro adhoc) -

- SUPERVISORY AND EXECUTIVE BOARDS’ PROPOSALS ADOPTED BY A LARGE 
MAJORITY - 2006 DIVIDEND RAISED TO €2.00 PER SHARE, PLUS A SPECIAL 
BONUS OF €0.50 - WACKER’S GROWTH CONTINUES IN Q1 2007 - FULL-YEAR 
SALES INCREASE EXPECTED TO EXCEED 10 PERCENT, WITH A HIGHER EBITDA 
MARGIN THAN LAST YEAR
  ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for
  the content of this announcement.
companies
May 29, 2007 - Wacker Chemie AG confirmed its
positive 2007 sales and earnings forecast at the first Annual 
Shareholder Meeting since its April 2006 IPO. Based on current 
exchange rates, the MDAX-listed Group expects sales in 2007 to be 
over 10 percent higher than last year. As for earnings, the EBITDA 
margin is estimated to show further increase. After posting its best 
results in over 90 years, the Munich-based chemical company is paying
out a total of EUR124.2 million (2006: EUR70.9m) to its shareholders.
This means each dividend-bearing share has earned EUR2, up from last 
year´s EUR1.60. Additionally, the shareholders approved a one-time 
special bonus of EUR0.50 per dividend-bearing share. They also 
adopted the Supervisory and Executive Boards´ other proposals by 
large majorities.
WACKER´s 2006 sales and earnings figures marked a new all time high. 
Sales increased 21 percent to EUR3.34 billion (2005: EUR2.76bn), with
net profit more than doubling to EUR311.3 million (2005: EUR143.7m).
The Group´s growth continued seamlessly into the first quarter of 
2007. Q1 sales rose to EUR943.7 million, 18 percent above the 
EUR798.5 million posted in Q1 2006. First-quarter net profit soared 
73 percent from EUR66.2 million to EUR114.5 million.
"Across the board, our figures clearly show we are on the right 
track," said CEO Peter-Alexander Wacker in Munich today. "Each of our
key business sectors is making good progress. What´s more, business 
is also profiting from renewable energy and other global trends, such
as energy-efficient construction and inroads made by electronics into
ever-more applications and walks of life. Consequently, I´m 
optimistic that WACKER will continue benefiting from the economy´s 
strength with above-average growth."
Resolutions and Voting Results At today´s Annual Shareholder Meeting,
43,354,345 voting shares were represented - 83.13 percent of all 
eligible shares (number of shares outstanding: 49,677,983). The 
voting results were as follows for agenda topics 2 through 7:
Topic 2: Resolution on the Appropriation of Net Retained Profit The 
Executive and Supervisory Boards proposed net retained profit for 
fiscal 2006, amounting to EUR763.6 million, to be appropriated as 
follows: EUR124.2 million to be paid to shareholders, EUR315 million 
to be kept as retained earnings and EUR324.4 million to be carried 
forward to new account. The proposal was adopted. The result was: - 
43,100,266 Yes votes (99.99 percent) - 876 No votes
Topic 3: Resolution on the Ratification of the Acts of the Executive 
Board The Executive and Supervisory Boards´ proposal to ratify the 
acts of the members of Wacker Chemie AG´s Executive Board during 
fiscal 2006 was adopted. The result was: - 43,000,586 Yes votes 
(99.99 percent) - 180 No votes
Topic 4: Resolution on the Ratification of the Acts of the 
Supervisory Board The Executive and Supervisory Boards´ proposal to 
ratify the acts of the members of Wacker Chemie AG´s Supervisory 
Board during fiscal 2006 was adopted. The result was: - 43,024,023 
Yes votes (99.99 percent) - 219 No votes
Topic 5: Resolution on the Appointment of Auditor The Supervisory 
Board´s proposal to appoint KPMG as auditor for fiscal 2007 was 
adopted. The result was: - 43,323,500 Yes votes (99.95 percent) - 
20,681 No votes
Topic 6: Approval of the Profit-and-Loss Transfer Agreement between 
Wacker Biotech GmbH and Wacker Chemie AG The Executive and 
Supervisory Boards´ proposal to approve the profit-and-loss transfer 
agreement between Wacker Biotech GmbH and Wacker Chemie AG was 
adopted. The result was: - 43,084,297 Yes votes (99.99 percent) - 97 
No votes
Topic 7: Authorization to Acquire Treasury Shares The Executive and 
Supervisory Boards´ proposal to authorize the Executive Board to 
acquire treasury shares representing up to 10 percent of the current 
share capital was adopted. The result was: - 43,068,830 Yes votes 
(99.94 percent) - 25,336 No votes
Information for editorial offices: All documents relating to the 2007
Annual Shareholding Meeting of Wacker Chemie AG can be downloaded 
from WACKER´s website (www.wacker.com) under Investor Relations.
This press release contains forward-looking statements based on 
assumptions and estimates of WACKER´s Executive Board. Although we 
assume the expectations in these forward-looking statements are 
realistic, we cannot guarantee they will prove to be correct. The 
assumptions may harbor risks and uncertainties that may cause the 
actual figures to differ considerably from the forward-looking 
statements. Factors that may cause such discrepancies include, among 
other things, changes in the economic and business environment, 
variations in exchange and interest rates, the introduction of 
competing products, lack of acceptance for new products or services, 
and changes in corporate strategy. WACKER does not plan to update the
forward-looking statements, nor does it assume the obligation to do 
so.
This press release contains statements about the resolutions of the 
2007 Annual Shareholder Meeting. These statements serve the sole 
purpose of providing an overview. They may not always correspond to 
the exact wording and full extent of the resolutions adopted at the 
Annual Shareholder Meeting.
end of announcement                               euro adhoc 29.05.2007 14:31:07

Further inquiry note:

Christof Bachmair
Media Relations & Information
Tel.: +49 (0)89 6279 1830
E-Mail: christof.bachmair@wacker.com

Branche: Chemicals
ISIN: DE000WCH8881
WKN: WCH888
Index: CDAX, Classic All Share, HDAX, MDAX, Midcap Market Index,
Prime All Share
Börsen: Frankfurter Wertpapierbörse / official dealing/prime standard

Original-Content von: Wacker Chemie AG, übermittelt durch news aktuell

Weitere Storys: Wacker Chemie AG
Weitere Storys: Wacker Chemie AG
  • 08.05.2007 – 07:32

    WACKER´s growth continues in Q1 2007

    - Q1 GROUP SALES RISE 18 PERCENT TO €944 MILLION - EBITDA JUMPS 45 PERCENT TO €266 MILLION, EBITDA MARGIN CLIMBS TO 28 PERCENT - CUSTOMER PREPAYMENTS BOOST NET CASH FLOW TO €224 MILLION - Q1 EARNINGS PER SHARE REACH €2.30 - STRONG RESULTS FOR 2007 EXPECTED ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. balance Munich (euro adhoc) - May 8, 2007 - ...

  • 18.04.2007 – 09:44

    euro adhoc: Wacker Chemie AG / Director's Dealings

    Notification concerning transactions by persons discharging managerial responsibilities pursuant to section 15a of the WpHG, transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement. 17.04.2007 Frankfurt (euro adhoc) - Details of the person subject to the disclosure requirement: Name: Franz-Josef Kortüm Name of ...

  • 17.04.2007 – 15:18

    euro adhoc: Wacker Chemie AG / Director's Dealings

    Notification concerning transactions by persons discharging managerial responsibilities pursuant to section 15a of the WpHG, transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement. 16.04.2007 Frankfurt (euro adhoc) - Details of the person subject to the disclosure requirement: Name: Dr. Susanne Weiss Name of ...